iRhythm launches next-generation long-term ECG monitoring patch
Click Here to Manage Email Alerts
Key takeaways:
- iRhythm announced the U.S. launch of its next-generation ECG monitoring patch.
- The patch is designed for use with the company’s new long-term continuous monitoring service.
iRhythm Technologies announced the U.S. launch of its next-generation cardiac monitoring patch and an enhanced long-term continuous monitoring service.
The new prescription-only ECG monitor (Zio) is small, lightweight and designed to improve the cardiac monitoring experience for patients and health care providers, according to a company press release.
Image: Adobe Stock
The new long-term continuous monitoring service (Zio LTCM) includes the cardiac monitoring patch, ECG utilization software (ZEUS System) and a comprehensive end-of-wear report reviewed by certified technicians, which has a 99% physician agreement, according to the release.
The next-generation ECG patch monitor features a hydrocolloid adhesive, has waterproof housing and is designed for up to 14 days of continuous wear, according to the release.
“When you combine our new Zio monitor with our advanced AI, efficient workflow, patient and clinician apps, and easy-to-read and actionable clinical reports, we continue to lead the way in the field,” Mintu Turakhia, MD, MAS, chief medical officer, chief scientific officer and executive vice president of product innovation at iRhythm, said in the release.
Collapse
Read more about
Click Here to Manage Email Alerts